Helius Medical Technologies Inc
NASDAQ:HSDT
Helius Medical Technologies Inc
NASDAQ:HSDT
Price:
2.11
USD
0.96%
Market Closed
Market Cap:
$87.1m
Relative Value
The Relative Value of one
HSDT
stock under the Base Case scenario is
0.04
USD.
Compared to the current market price of 2.11 USD,
Helius Medical Technologies Inc
is
Overvalued by 98%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
HSDT
Relative Value
Base Case
0.04
USD
Overvaluation 98%
Multiples Across Competitors
HSDT Competitors Multiples
Helius Medical Technologies Inc Competitors
Helius Medical Technologies Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Helius Medical Technologies Inc
NASDAQ:HSDT
|
85m USD | 90.4 | -0.2 | 2.5 | 2.5 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
187.6B USD | 4.2 | 28.8 | 16.5 | 22.6 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
167.7B USD | 16.7 | 58.7 | 44.5 | 54.7 | |
| US |
|
Stryker Corp
NYSE:SYK
|
128.8B USD | 5.1 | 39.7 | 20.3 | 24.5 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
111.8B USD | 3.2 | 24.2 | 13.4 | 19.5 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
102.5B USD | 5.1 | 35.4 | 20.8 | 27.9 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
43.9B EUR | 1.9 | 20.7 | 11.5 | 16.2 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.5B USD | 7.8 | 44.3 | 24.3 | 26.6 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
45.4B USD | 2.1 | 25.8 | 10.2 | 17.2 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.7B USD | 10.6 | 43.2 | 30.7 | 34 | |
| US |
|
Resmed Inc
NYSE:RMD
|
33.6B USD | 6.2 | 22.6 | 15.9 | 17.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
